We develop and market high-quality blood volume measurement devices. Our ambition is to make blood volume assessment a clinically applicable tool worldwide. We believe this to be highly beneficial to a great number of critically ill patients.
Detalo Health is founded in 2018 by Professor Carsten Lundby and Jonas Bechlund. Detalo is Esperanto for ‘detail’ and signifies the importance of precise and accurate blood volume quantification in medical treatment, as well as our dedication to quality first work ethos.
The development of the Detalo Clinical was initiated in 2015 and was based on a decade of experience with blood volume assessments in humans using various techniques. Prior to the launch of the device, numerous different prototypes had been constructed and tested. Today the Detalo devices are the only CE-approved device that can be used to determine hemoglobin mass and blood volume in humans.